Locations:
Search IconSearch
September 3, 2021/Neurosciences/Podcast

A Team Approach to Treating Orbital Tumors (Podcast)

Multidisciplinary expertise is key to removing tumors in the orbital apex and posterior intraconal space

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Schwannomas of the orbit are rare, accounting for fewer than 6% of all orbital tumors. Because schwannomas and other orbital tumors can be difficult to manage in the narrow setting of the optic canal, a multidisciplinary team approach is essential to their removal.

“In neurosurgery, dealing with issues of the skull base has historically been a largely solitary endeavor, with one surgeon taking on the challenge by him- or herself,” says Pablo Recinos, MD, a neurosurgeon in Cleveland Clinic’s Neurological Institute. “Now, we have turned the page and see that we can accomplish a lot more through a multidisciplinary approach.”

Dr. Recinos partners with Raj Sindwani, MD, a rhinologic surgeon in Cleveland Clinic’s Head & Neck Institute, and colleagues from other subspecialties to treat tumors in the orbital apex and posterior intraconal space. In the most recent episode of Cleveland Clinic’s Neuro Pathways podcast, the two surgeons discuss the diagnosis and management of orbital tumors, including:

  • Clinical manifestations in patients with tumors of the orbit
  • Treatment options for orbital schwannomas, meningiomas and hemangiomas
  • Emerging endonasal surgical approaches
  • Outcomes for patients with orbital tumors

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Sindwani: [With the endonasal approach] essentially we use the nose and sinuses, which are largely filled with air, as a corridor to get to the back of the eye. Then we gently take down the bone partitioning the nose from the eye and access the tumor through that direct line approach to the orbit.

Advertisement

Dr. Recinos: I would add that our experience has grown from starting with pituitary surgery … the most common procedure that we do together. However, flanked on each side of the pituitary gland are the optic nerves, and then the orbit. So these are natural areas that we work in, both for tumors that arise from the intracranial space but also now for ones that arise primarily within the back of the orbit. Working together to tackle problems in this area is a natural extension of where we have worked together in the past.

Dr. Sindwani: That’s a good point, Pablo, and the approach of having two surgeons using multiple hands, with multiple instruments going through the nose, is actually exactly the same that we use for pituitary tumors and other skull base tumors. Essentially this multi-handed technique is what allows us to safely dissect, resect and retract structures within the orbit — in this case, to then safely remove the tumor without disrupting any of the normal critical structures that are nearby.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad